Get Sample Pages - Cell Gene Therapy Drug Delivery Devices Market Growth Till 2030

Global Cell & Gene Therapy Drug Delivery Devices Market Research Report: Forecast (2025-2030)

By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Fi......lled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)), By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By End-Users (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics) Read more

Healthcare
Jul 2025
Pages 221
Report Format: PDF, Excel, PPT

Market Definition

Cell & gene therapies involve the extraction of protein, cells, or genetic material from the patient, modifying them, and then re-injecting into the patient to provide a highly personalized treatment. These therapies have immense potential to display long-lasting effects.

Market Insights & Analysis: Global Cell & Gene Therapy Drug Delivery Devices Market (2025-30):

The Global Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials. Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years

Report Coverage	Details
Study Period	Historical Data: 2020-23
	Base Year: 2024
	Forecast Period: 2025-30
CAGR (2023-2028)	10.53%
Regions Covered	North America: USA, Canada, Mexico
	Europe: Germany, UK, France, Italy, Spain
	Asia-Pacific: China, India, Japan, South Korea
	South America: Brazil, and Argentina
	Middle East & Africa: UAE, Saudi Arabia, Qatar, Israel, South Africa
Key Companies Profiled	Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation
Unit Denominations	USD Million/Billion

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

The market dynamics underwent significant disruptions in manufacturing & logistics processes and faced substantial complexities in the supply chain of materials. Owing to this, many clinical centers had to suspend their operations to combat the risk of virus exposure. Moreover, shipment delays risked the short shelf lives of cell therapies that need transportation across manufacturing sites & administration centers within tight timeframes.

However, observing the increasing spread of the dreadful disease, market players shifted their focus majorly on addressing challenges associated with the pandemic. Numerous gene therapy companies got involved in the research & manufacturing of Covid-19 vaccinations since the currently available ones are authorized for clinical development & based on mRNA or viral vector approaches. As a result, prices & reimbursements of Competitive Generic Therapy (CGTs) expanded significantly.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Executive Summary
Impact of Covid-19 on Global Cell & Gene Therapy Drug Delivery Devices Market
Global Cell & Gene Therapy Drug Delivery Devices Market Policies & Regulations
Global Cell & Gene Therapy Drug Delivery Devices Success & Growth
Global Cell & Gene Therapy Drug Delivery Devices Market Trends & Insights
Global Cell & Gene Therapy Drug Delivery Devices Market Dynamics
1. Impact Analysis
2. Drivers
3. Challenges
Global Cell & Gene Therapy Drug Delivery Devices Market Trends & Development
Global Cell & Gene Therapy Drug Delivery Devices Market Analysis, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
    1. Sub-retinal Injection Cannula
    2. Extension Tube
    3. Intravenous Catheter
    4. Sterile Insulin Syringe
      1. Size 1.0 ML, 31-Gauge Needle
      2. Size 0.5 ML, 22-Gauge Needle
    5. Pre-Filled Syringe
      1. Size 1.0 ML, 22-26 Gauge Needle
      2. Size 4.0 ML, 22-26 Gauge Needle
    6. Infusion Bags
      1. Infusion Bags (Size 10 ML to 50 ML)
      2. Infusion Bags (Size 68 ML)
      3. Infusion Bags (Size 60 ML)
      4. Infusion Bags (Size Up to 65 ML)
  2. By Technology
    1. Microchip Technology
    2. Nano-Technology
    3. Lipid Nanoparticles
  3. By Commercialized Drugs
    1. Luxturna
    2. Kymriah
    3. Yescarta
    4. Zolgensma
    5. Provenge
    6. Strimvelis
  4. By End-User
    1. Pharmaceuticals & Biotechnology Company
    2. Academic & Research Institute
    3. Hospitals & Clinics
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
North America Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Commercialized Drugs
  4. By End-User
  5. By Country
    1. US
    2. Canada
    3. Mexico
3. The US Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
4. Canada Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
5. Mexico Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
South America Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Commercialized Drugs
  4. By End-User
  5. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Brazil Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
4. Argentina Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
Europe Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Commercialized Drugs
  4. By End-User
  5. By Country
    1. The UK
    2. Spain
    3. Italy
    4. France
    5. Germany
    6. Others
3. The UK Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
4. France Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
5. Germany Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
6. Spain Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
7. Italy Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
Middle East & Africa Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Commercialized Drugs
  4. By End-User
  5. By Country
    1. Saudi Arabia
    2. The UAE
    3. Qatar
    4. Israel
    5. South Africa
    6. Others
Asia-Pacific Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
1. Market Size & Analysis
  1. By Revenue
  2. By Unit Sold
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Commercialized Drugs
  4. By End-User
  5. By Country
    1. India
    2. China
    3. Japan
    4. South Korea
    5. Others
3. China Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
4. India Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
5. Japan Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
6. South Korea Cell & Gene Therapy Drug Delivery Devices Market Outlook, 2018-2028
  1. Market Size & Analysis
    1. By Revenue
    2. By Unit Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Technology
Competitive Benchmarking
1. Competition Matrix
  1. Company Overview
  2. Product/Business Segment Overview
  3. Regulatory & Legal Development
  4. Company Strategies
  5. SWOT Analysis
Company Profile
1. Amgen Inc.
2. Bausch & Lomb Incorporated
3. Becton, Dickinson and Company
4. Bluebird bio Inc.
5. Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
6. Dendreon Pharmaceuticals LLC
7. Helixmith Co. Ltd (ViroMed Co., Ltd)
8. Human Stem Cells Institute
9. Kite Pharma Inc.
10. Kolon TissueGene, Inc.
11. Novartis AG
12. Orchard Therapeutics plc.
13. Pfizer Inc.
14. Renova Therapeutics
15. Spark Therapeutics Inc.
16. uniQure N.V.
17. Vericel Corporation
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *